Skip to main content
TipRanks
Go Ultimate75% OFF

Orthofix Medical (OM2) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Orthofix Medical has a market cap or net worth of EUR 245.60M. The enterprise value is EUR 562.65M.

Market Cap
EUR 245.60M
Enterprise Value
EUR 562.65M

Share Statistics

Orthofix Medical has 40,759,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
40,759,800
Owned by Insiders
28.28%
Owned by Institutions
46.42%

Financial Efficiency

Orthofix Medical’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -10.01%.

Return on Equity (ROE)
-0.20
Return on Assets (ROA)
-0.11
Return on Invested Capital (ROIC)
-10.01%
Return on Capital Employed (ROCE)
-0.10
Revenue Per Employee
512.34K
Profits Per Employee
-57.44K
Employee Count
1,605
Asset Turnover
0.97
Inventory Turnover
7.92

Valuation Ratios

The current PE Ratio of Orthofix Medical is -5.93. Orthofix Medical’s PEG ratio is -0.06.

PE Ratio
-5.93
PS Ratio
0.32
PB Ratio
0.63
Price to FCF
-6.17
Price to Operating Cash Flow
54.33
PEG Ratio
-0.06

Income Statement

In the last 12 months, Orthofix Medical had revenue of 822.31M and earned -92.19M in profits. Earnings per share was -2.28.

Revenue
822.31M
Gross Profit
551.71M
Operating Income
-68.47M
Pretax Income
-90.81M
Net Income
-92.19M
EBITDA
9.93M
Earnings Per Share (EPS)
-2.28

Cash Flow

In the last 12 months, operating cash flow was 5.01M and capital expenditures -48.68M, giving a free cash flow of -43.67M billion.

Operating Cash Flow
5.01M
Free Cash Flow
-43.67M
Free Cash Flow per Share
-1.06

Dividends & Yields

Orthofix Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-16.21%
Earnings Yield
-16.53%

Stock Price Statistics

Beta
0.35
52-Week Price Change
-53.17%
50-Day Moving Average
7.78
200-Day Moving Average
9.06
Relative Strength Index (RSI)
31.71
Average Volume (3m)
25

Important Dates

Orthofix Medical upcoming earnings date is Feb 19, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 09, 2026
Next Earnings Date
Feb 19, 2027
Ex-Dividend Date
―

Financial Position

Orthofix Medical as a current ratio of 2.45, with Debt / Equity ratio of 50.94%

Current Ratio
2.45
Quick Ratio
2.24
Debt to Market Cap
0.31
Net Debt to EBITDA
14.82
Interest Coverage Ratio
-3.92

Taxes

In the past 12 months, Orthofix Medical has paid 1.38M in taxes.

Income Tax
1.38M
Effective Tax Rate
-0.02

Enterprise Valuation

Orthofix Medical EV to EBITDA ratio is 4.38, with an EV/FCF ratio of -9.57.

EV to Sales
0.50
EV to EBITDA
4.38
EV to Free Cash Flow
-9.57
EV to Operating Cash Flow
83.42

Balance Sheet

Orthofix Medical has EUR 86.32M in cash and marketable securities with EUR 234.85M in debt, giving a net cash position of -EUR 148.53M billion.

Cash & Marketable Securities
EUR 86.32M
Total Debt
EUR 234.85M
Net Cash
-EUR 148.53M
Net Cash Per Share
-EUR 3.64
Tangible Book Value Per Share
EUR 4.17

Margins

Gross margin is 69.17%, with operating margin of -0.65%, and net profit margin of -5.39%.

Gross Margin
69.17%
Operating Margin
-0.65%
Pretax Margin
-5.18%
Net Profit Margin
-5.39%
EBITDA Margin
11.41%
EBIT Margin
-2.36%

Analyst Forecast

The average price target for Orthofix Medical is EUR 9.10, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
EUR 9.10
Price Target Upside
54.16% Upside
Analyst Consensus
Moderate Buy
Analyst Count
3
Revenue Growth Forecast
-2.99%
EPS Growth Forecast
66.06%

Scores

Smart Score
5
AI Score
―